LAMP2 and primary biliary cholangitis: In summary, the present study suggested that high baseline serum levels of LAMP-2 might indicate an advanced histological stage of PBC and a 35% decrease in serum LAMP-2 might be used as a predictor to identify patients who would undergo response to UDCA therapy.